Grantham, Mayo, Van Otterloo & Co (GMO)’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
Grantham, Mayo, Van Otterloo & Co (GMO)'s G Position: Q3 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Genpact (G) stake by 22% in Q3 2026, buying an estimated $403K and bringing the position to 64,969 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #442.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in G in Q3 2019 and has held it in 15 quarters since. The position peaked at $7.26M in Q4 2022. 489 funds tracked by Wall St. Rank hold G as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 64,969 shares of Genpact worth $2.11M as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 11,910 Genpact shares in Q3 2026, an estimated $403K.
- Genpact made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #442 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Genpact in Q3 2019 and has held it in 15 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Genpact position peaked at $7.26M in Q4 2022.
- 489 funds tracked by Wall St. Rank held Genpact as of Q3 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.